Olive P Khaliq1, Tadashi Konoshita2, Jagidesa Moodley3, Thajasvarie Naicker4. 1. Optics and Imaging Centre, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa. saminah.khaliq@gmail.com. 2. Third Department of Internal Medicine, University of Fukui Faculty of Medicine Sciences, Fukui, Japan. 3. Department of Obstetrics and Gynaecology and Women's Health and HIV Research Group, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa. 4. Optics and Imaging Centre, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa. naickera@ukzn.ac.za.
Abstract
PURPOSE OF REVIEW: Because of the significant discrepancies on this topic, this review will focus on the role of uric acid in PE, uric acid as a predictor of preeclampsia and fetal growth retardation. We considered eligible review and original articles relevant to the research question. RECENT FINDINGS: Hypertensive disorders of pregnancy such as preeclampsia (PE) are a major cause of both maternal and fetal morbidity and mortality worldwide. Uric acid has been reported as a key factor contributing to the pathogenesis of PE. Some studies have indicated that serum uric acid levels increase with the severity of PE, while several studies have shown contradictory results. Some studies suggested high uric acid levels lead to PE, while others state that PE causes an increase in uric acid levels. Despite the strong association of uric acid in the pathogenesis of preeclampsia, current data is still contradictory hence genetic and high-end laboratory investigations may clarify this enigma.
PURPOSE OF REVIEW: Because of the significant discrepancies on this topic, this review will focus on the role of uric acid in PE, uric acid as a predictor of preeclampsia and fetal growth retardation. We considered eligible review and original articles relevant to the research question. RECENT FINDINGS:Hypertensive disorders of pregnancy such as preeclampsia (PE) are a major cause of both maternal and fetal morbidity and mortality worldwide. Uric acid has been reported as a key factor contributing to the pathogenesis of PE. Some studies have indicated that serum uric acid levels increase with the severity of PE, while several studies have shown contradictory results. Some studies suggested high uric acid levels lead to PE, while others state that PE causes an increase in uric acid levels. Despite the strong association of uric acid in the pathogenesis of preeclampsia, current data is still contradictory hence genetic and high-end laboratory investigations may clarify this enigma.
Entities:
Keywords:
Hypertensive disorders of pregnancy; Hyperuricemia; Preeclampsia; Uric acid
Authors: Kelly K Ferguson; John D Meeker; Thomas F McElrath; Bhramar Mukherjee; David E Cantonwine Journal: Am J Obstet Gynecol Date: 2016-12-30 Impact factor: 8.661
Authors: James M Roberts; Lisa M Bodnar; Kristine Y Lain; Carl A Hubel; Nina Markovic; Roberta B Ness; Robert W Powers Journal: Hypertension Date: 2005-10-24 Impact factor: 10.190
Authors: Joel R Livingston; Beth Payne; Mark Brown; James M Roberts; Anne-Marie Côté; Laura A Magee; Peter von Dadelszen Journal: J Obstet Gynaecol Can Date: 2014-10
Authors: Jenna L Riis; Stephanie H Cook; Nicole Letourneau; Tavis Campbell; Douglas A Granger; Gerald F Giesbrecht Journal: Front Endocrinol (Lausanne) Date: 2022-03-18 Impact factor: 5.555
Authors: Jean Michell Santoyo; José Antonio Noguera; Francisco Avilés; Juan Luis Delgado; Catalina de Paco-Matallana; Virginia Pérez; Isabel Hernández Journal: Antioxidants (Basel) Date: 2022-07-21